跳至主要内容
临床试验/CTRI/2011/12/002262
CTRI/2011/12/002262已完成1 期

PHARMACEUTICAL STANDARDIZATION OF KUKKUTANDA TVAK BHASMA PREPARED BY TWO DIFFERENT METHODS AND ITS EFFECT ON ASTHIKSHAYA (OSTEOPOROSIS)

IPGTRA0 个研究点目标入组 18 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • An osteoporotic patient of either sex between 30 to 70 yrs whose BMD (t-score) is equal to or less than -1.
  • Patients presenting with the classical symptoms of Asthikshaya vis-a-vis Osteoporosis.

排除标准

  • Age below 30 and above 70 years.
  • BMDââ?¬Ë?tââ?¬•-score above-1.
  • Patients suffering from neoplasm of the bone.
  • Known cases of Diabetes mellitus, uncontrolled Hypertension, Thyrotoxicosis, Hyper parathyroidism, Addisonââ?¬•s disease, Pagetââ?¬•s disease, Cushingââ?¬•s syndrome, Tuberculosis of the bone, Osteomalacia, and Chronic renal disease D, Hepatic and Cardiac failure.
  • Rheumatoid arthritis

研究者

发起方
IPGTRA

相似试验